News stories about II-VI (NASDAQ:IIVI) have been trending positive this week, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. II-VI earned a media sentiment score of 0.33 on Accern’s scale. Accern also gave news articles about the scientific and technical instruments company an impact score of 46.6125443512315 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
- II-VI Incorporated Launches Ultraviolet Fluorescence Filters for … – GlobeNewswire (press release) (globenewswire.com)
- II-VI, Inc. (IIVI) Announces ISO 13485 Certification of Dallas Site – StreetInsider.com (streetinsider.com)
- II-VI Incorporated Announces ISO 13485 Certification of Dallas Site to Design and Manufacture FDA Approved Biomedical Assemblies (finance.yahoo.com)
- II-VI Incorporated Launches Ultraviolet Fluorescence Filters for Biomedical Instruments (finance.yahoo.com)
- Earnings Season Preview: II-VI Near Buy Zone With Quarterly Report Due (finance.yahoo.com)
Shares of II-VI (NASDAQ IIVI) traded down $1.10 during trading hours on Wednesday, reaching $50.35. The company had a trading volume of 480,200 shares, compared to its average volume of 561,230. II-VI has a 52 week low of $27.25 and a 52 week high of $52.55. The company has a market capitalization of $3,210.00, a PE ratio of 32.69 and a beta of 0.03. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.63 and a current ratio of 3.89.
II-VI (NASDAQ:IIVI) last announced its quarterly earnings data on Tuesday, October 31st. The scientific and technical instruments company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.04). II-VI had a return on equity of 12.25% and a net margin of 9.89%. The firm had revenue of $261.50 million during the quarter, compared to the consensus estimate of $255.20 million. During the same period last year, the company earned $0.35 EPS. The firm’s revenue for the quarter was up 18.1% compared to the same quarter last year. sell-side analysts anticipate that II-VI will post 1.55 EPS for the current fiscal year.
A number of research firms have recently commented on IIVI. BidaskClub raised II-VI from a “hold” rating to a “buy” rating in a research note on Wednesday, January 10th. Needham & Company LLC upped their target price on II-VI from $50.00 to $56.00 and gave the company a “buy” rating in a research note on Monday, November 13th. Zacks Investment Research cut II-VI from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. ValuEngine cut II-VI from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Finally, B. Riley upped their target price on II-VI from $39.50 to $40.50 and gave the company a “neutral” rating in a research note on Wednesday, November 1st. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $50.64.
In other II-VI news, Director Francis J. Kramer sold 25,000 shares of the stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of $45.10, for a total transaction of $1,127,500.00. Following the sale, the director now owns 286,259 shares of the company’s stock, valued at approximately $12,910,280.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Mary Jane Raymond sold 1,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were sold at an average price of $45.00, for a total value of $45,000.00. Following the sale, the chief financial officer now directly owns 53,415 shares in the company, valued at approximately $2,403,675. The disclosure for this sale can be found here. In the last three months, insiders sold 36,712 shares of company stock worth $1,699,046. 3.80% of the stock is owned by insiders.
II-VI Company Profile
II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.
Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.